Cancer survivors face a new threat: heart damage caused by the very treatments that saved their lives. While therapies like chemotherapy, radiation, and immunotherapy can be lifesaving, they often cause silent, long-term cardiac harm that goes undetected until it’s too late. ViviScout addresses this urgent gap with a precision wearable platform that provides continuous, real-time heart monitoring tailored to each survivor’s treatment history. Focused on high-risk cancers like breast, lymphoma, and leukemia, ViviScout empowers early detection and intervention to prevent heart failure and protect survivor health. Because beating cancer should be the beginning of a strong, healthy future—not the start of a new risk.